Cargando…
High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage
BACKGROUND: Clinical activity of ankylosing spondylitis (AS) predicts the natural course of the disease and the response to treatment. Several molecules are involved in new bone formation resulting in structural damage in patients with AS. However, the link between the clinical and molecular phenome...
Autores principales: | Korkosz, Mariusz, Gąsowski, Jerzy, Leszczyński, Piotr, Pawlak-Buś, Katarzyna, Jeka, Sławomir, Kucharska, Ewa, Grodzicki, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639156/ https://www.ncbi.nlm.nih.gov/pubmed/23509994 http://dx.doi.org/10.1186/1471-2474-14-99 |
Ejemplares similares
-
Baseline new bone formation does not predict bone loss in ankylosing spondylitis as assessed by quantitative computed tomography (QCT) - 10-year follow-up
por: Korkosz, Mariusz, et al.
Publicado: (2011) -
Endothelial dysfunction in patients with ankylosing spondylitis
por: Łosińska, Katarzyna, et al.
Publicado: (2019) -
Coexistence of rheumatoid arthritis and ankylosing spondylitis
por: Barczyńska, Tacjana Anna, et al.
Publicado: (2015) -
Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
por: Guła, Zofia, et al.
Publicado: (2017) -
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2018)